Abstract Prostate MRI has seen rapid growth in use in recent years as an advanced diagnostic modality to detect focal areas of clinically significant prostate cancer, identify an area for targeted biopsy, and guide management and surveillance. The increase in use has also led to increased...
Screening and Prevention of Prostate Cancer 2021 (Part 2): Who Needs a Biopsy? – Summary: In part 2 of a 3-part series, Sigrid V. Carlsson, MD, Ph.D., MPH, Assistant Attending Epidemiologist at Memorial Sloan Kettering Cancer Center, goes over her 5 Golden Rules for prostate cancer testing...
Screening and Prevention of Prostate Cancer 2021 (Part 3): Incorporating MRI for Early Detection – Summary: In the final part of a 3-part series, Sigrid V. Carlsson, MD, Ph.D., MPH, Assistant Attending Epidemiologist at Memorial Sloan Kettering Cancer Center, considers the current role of MRI...
Abstract Multiparametric magnetic resonance imaging (MRI) and MRI-guided prostate biopsy have become the standard for prostate cancer diagnosis. As their implementation is relatively recent, experience is still limited in various centers. An MRI-guided biopsy requires basic knowledge in...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.